Figure 1. Frequency of driver mutations in lung adenocarcinoma.
A. and lung adenocarcinoma “pan-negative” for mutations in EGFR kinase domain, KRAS, HER2 kinase domain, BRAF, ALK, ROS1 and RET B.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.